## TPR: Tapestry, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.37 indicates fundamental undervaluation. Quality metrics strong (ROE 16%). Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (71).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($115.51)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Tapestry (TPR) Stock Trades Down, Here Is Why**
- Source: Finviz | 20251210T140600 | Neutral | Relevance: 98%
-  Tapestry (NYSE:TPR) shares fell 1.9% after Guggenheim initiated coverage with a "Neutral" rating, suggesting the stock is fairly valued without immediate growth catalysts. This dip follows a period of strong performance for the luxury fashion conglomerate, with its stock reaching an all-time high in the previous trading session. The marketâ€™s reaction despite strong recent performance highlights sensitivity to analyst sentiment.

**2. Tapestry Inc. stock rises Thursday, outperforms market**
- Source: MarketWatch | 20251211T163000 | Bullish | Relevance: 97%
- Tapestry Inc. (TPR) stock surged by 4.89% on Thursday, reaching $123.49 and outperforming the broader market. The company also achieved a new 52-week high, surpassing its previous peak set on December 9th. This robust performance occurred on a positive day for the stock market, with both the S&P 500 and Dow Jones Industrial Average posting gains.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-11-17 | JP Morgan | $148 | $147 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | init | Neutral |
| 2025-11-17 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($1.60M) |
| Sells | 10 ($7.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-1.8%)
- Blackrock Inc.: 9.4% (+14.0%)
- State Street Corpora: 4.5% (+19.3%)
- FMR, LLC: 3.6% (-33.3%)
- Geode Capital Manage: 2.8% (+3.8%)

### Key Risks

1. Insider selling cluster: $7.9M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.37 indicates undervaluation relative to growth. Insider selling cluster ($7.9M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $25.6B |
| Beta | 1.67 |
| 52W Range | $58.39 - $123.55 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.37 |
| Forward P/E | 20.0 |
| Current P/E | 22.1 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 6.7% to 10.3% (+3.7% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (10.3% > 10.0%), caution on chasing. MRS_5 at 4.1% confirms short-term momentum alignment. AM_20 at 12.7% shows strong absolute momentum above own 20MA. Outperforming sector by 9.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.67), confirming momentum. RSI overbought at 71, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 10.33% (CS: 94) | Strong |
| RSI_14 | 70.8 | Overbought |
| MACD Histogram | 1.67 | Bullish |
| vs SMA20 | 1.126x | Above |
| vs SMA50 | 1.112x | Above |
| vs SMA200 | 1.315x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $123.49
- **Stop Loss:** $115.51 (6.5% risk)
- **Target:** $139.45 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 172
- **Position Value:** $21,240.28
- **Portfolio %:** 21.24%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $2.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.26 | $1.38 | +9.4% |
| 2025Q2 | $1.02 | $1.04 | +2.1% |
| 2025Q1 | $0.88 | $1.03 | +17.1% |
| 2024Q4 | $1.75 | $2.00 | +14.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*